About Me
Anthony Sung, MD, is the A. Drue Jennings Professor in Medical Oncology, Professor of Medicine in Division of Hematologic Malignancies and Cellular Therapeutics, Scientific Director of the Digital Health Co/Lab, and Director of the Center for Survivorship and Patient-Oriented Research. California born and bred, he received his undergraduate degree from Stanford University, though he spent his junior year "abroad" at Deep Springs College. He subsequently received his MD from Harvard Medical School, did his internship and residency in internal medicine at Johns Hopkins Hospital in the Osler Medical Housestaff Training Program, and fellowship in hematology/oncology at Duke University. Upon completion of his training, he spent 10 years on the faculty at Duke, where he served as Associate Director of the Duke Microbiome Center and a Senior Fellow in the Duke Center for the Study of Aging and Human Development before coming to KUMC in 2024. In addition to his work at KUMC, Dr. Sung is a Special Government Employee of the United States Food and Drug Administration (FDA) and ad hoc member of the FDA Oncologic Drug Advisory Committee (ODAC); a member of the American Society of Hematology (ASH) Subcommittee on Emerging Gene and Cellular Therapies, and a member of the Bone Marrow Transplant Clinical Trials Network (BMT CTN) Toxicity and Supportive Care Committee.